View Document Preview and Link Document Date: 2015-02-11 11:06:11 Open Document File Size: 2,72 MB Share Result on Facebook
City EVIDENCED / Philadelphia / Boston / Cambridge / London / / Company Novartis / Allergan / Polkinghorne P. Management / Alimera Sciences / Genentech / MEAD / BMJ Publishing Group / AMD / Ulbig MW / Regeneron Pharmaceuticals / DRCR.net / Optos / SurModics / / Continent America / / Country United States / / Currency USD / AMD / / Event FDA Phase / / Facility National Institute of Diabetes / University of Medicine / Thomas Jefferson University / / IndustryTerm retinal imaging case examples / postoperative fundus imaging / imaging / autofluorescence imaging / product/device / Diabetes Care / clinical study dosing protocols / treatment algorithm / ranibizumab groups / respective product / intravitreal delivery systems / products/devices / Online Courses / high-resolution multimodal imaging / care for patients with these diseases / systemic diabetes management / pharmaceutical therapies / patient-initiated home screening devices / care for the disease / glycation end products / services / / MedicalCondition macular edema / very mild / high-risk proliferative diabetic retinopathy / tractional retinal detachment / retinal diseases / cysts / significant disease / macular degeneration / vision disorders / Practice Management TRACTIONAL DIABETIC MACULAR EDEMA / coincident systemic disease / systemic disease / chronic detachment / nonproliferative diabetic retinopathy / pulmonary edema / very significant disease / proliferative diabetic retinopathy / systemic diabetes / II diabetes / diabetic retinopathy / endothelial dysfunction / diabetes / concomitant epiretinal membrane / diseases / vitreoretinal interface disorder / diabetic macular edema / retinal vein occlusion / foveal depression / hypercholesterolemia / advanced disease / background diabetic retinopathy / intracellular hyperglycemia / diabetic retinopathy study report number / combined rhegmatogenous retinal detachment / potential choroidal neovascularization / RVO-related macular edema / obesity / retinal vascular diseases / mild disease / reasonably well-controlled diabetes / diabetic retinopathy level / blindness / hypertension / Epiretinal membrane / disease / clinically significant macular edema / retinal vascular disease / Kidney Diseases / recalcitrant macular edema / subclinical disease / advanced retinal disease / retinal disease / retinal neovascularization / inflammation / diabetic retinopathy study research group / / MedicalTreatment surgery / laser therapy / pharmacotherapy / counseling / photodynamic therapy / laser treatments / / Organization National Eye Institute / MA FACULTY / Wills Eye Hospital / University of Medicine and Dentistry New Brunswick / Dulaney Foundation / Thomas Jefferson University Philadelphia / Prevent Blindness America Foundation / Accreditation Council for Continuing Medical Education / Diabetic Retinopathy Clinical Research Network Writing Committee / National Institute of Diabetes / Harvard / American Diabetes Association / Centers for Disease Control and Prevention / US Food and Drug Administration / Retina Vitreous Center Robert Wood Johnson Medical School / / Person Moderator Dean Eliott / Mant / Carl Regillo / Carl D. Regillo / Chirag P. Shah / Jonathan L. Prenner / Robert Wood Johnson / Dean Eliott / Arch Ophthalmol / / Position Director of the Retina Service Massachusetts Eye / retinal specialist / vitreoretinal surgeon / Director of the Retina Service / Professor / surgeon / forward / Assistant / Professor of Ophthalmology / MPH Vitreoretinal Specialist / chair / / Product FS / Macugen / Avastin / triamcinolone acetonide / FML / BRAVO / fluocinolone acetonide / dexamethasone / triamcinolone / Lucentis / indocyanine green / COPERNICUS21 / / ProvinceOrState Maine / / Technology tomography / pdf / laser / treatment algorithm / lasers / clinical study dosing protocols / / URL http / SocialTag 
Supplement to January/February 2015 VI